ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Taro Pharmaceutical Industries Ltd. (TARO) Report Updated: Sep 26, 2016 | Print This Page

Get more stock ratings by Louis Navellier

Taro Pharmaceutical Industries Ltd. (TARO)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Pharmaceuticals
Competitors: AMPH,JNJ,HSKA,SUPN
service keys

Taro Pharmaceutical Industries Ltd.© quotemedia

Company Profile

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, engages in the development, manufacture, and marketing of pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It sells and distributes its products principally to drug industry wholesalers, drug store chains, mass merchandisers, healthcare institutions, and private pharmacies. The company was founded in 1959 and is based in Haifa Bay, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Sun Pharmaceutical Industries Ltd.